MyAverix Finance
F · Healthcare
NANOFORM FINLAND OYJ (4YL)
Biotechnology
NANOFORM FINLAND OYJ (4YL) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4YL
NANOFORM FINLAND OYJ (4YL) — FAQ
What is 4YL's P/E ratio?
The price-to-earnings (P/E) ratio for NANOFORM FINLAND OYJ (4YL) is 25.00 (data as of 2026-05-23).
Does NANOFORM FINLAND OYJ pay a dividend?
Dividend yield is not available in the current snapshot for NANOFORM FINLAND OYJ (4YL). Check the MyAverix Finance app for the latest dividend data.
What sector is NANOFORM FINLAND OYJ in?
NANOFORM FINLAND OYJ (4YL) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 4YL listed on?
4YL is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.